Virtual Self-Management Program for JIA
Feasibility and Acceptability of a Virtual Self-management Program - A Pilot Randomized Controlled Trial for Adolescents With Juvenile Idiopathic Arthritis
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this project is to conduct a pilot randomized controlled trial (RCT) to evaluate the feasibility and preliminary effectiveness of a virtual group based self-management program (SMP) in adolescents with JIA across different provinces compared to a wait-list control group receiving only standard of care. Participants in the SMP group will partake in four 60-90 minute group sessions conducted over 8 weeks. The intervention is a multifaceted program that includes JIA disease education, self-management strategies, and peer support. Both the interventional and control group will be asked to complete baseline and post-test measures. Participants in the control group will be offered the SMP after completion of the post-control outcome measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2023
CompletedStudy Start
First participant enrolled
December 13, 2023
CompletedFirst Posted
Study publicly available on registry
December 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedDecember 9, 2024
October 1, 2024
2 years
November 10, 2023
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Program Adherence Rates (feasability)
The primary objective is feasibility outcome that will be measured as adherence with the SMP Program. This is defined as Proportion of completed questionnaires (defined as 80% when all measures are completed) at baseline and 8 weeks post-randomization in both groups along with recruitment and withdrawal rates. (\>80% recruitment rate and \<80% withdrawal)
3 months
Satisfaction of Program
Satisfaction with the SMP as measured through a semi-structured virtual interview with the participants following involvement in the SMP to capture participants' experience.
3 months
Intervention fidelity
We are looking at consistent content and technology delivery. This will be assessed by i) Observational checklists ii) qualitative analysis of recorded video sessions after 2, 4 and at completion of all sessions by each facilitator to ensure sessions are consistently delivered and as planned.
3 months
Secondary Outcomes (5)
Understanding of JIA
3 months
Understanding of Arthritis Self Efficacy
3 months
Quality of Life for Teens
3 months
Physical Pain Level
3 months
How Prepared the patient feels for Adult Care
3 months
Study Arms (2)
SMP Program with Standard Care
EXPERIMENTALfour 60-90 minute virtual educational sessions over 8 weeks with a group of 4-6 participants
Standard Care Only
ACTIVE COMPARATORStandard of care(no formal education program similar to SMP) and placed on 8-week waitlist for optional intervention.
Interventions
Four sessions, 60-90 minutes each, will be conducted over eight weeks with a group size of 4-6 participants via videoconferencing platforms such as Zoom or Microsoft Teams. Each session will include Power Point delivered presentations, interactive activities, and group discussions. This is a multifaceted program that includes JIA disease education, self-management strategies, and peer support.
Eligibility Criteria
You may qualify if:
- Adolescents between the ages of 12 and 17
- Confirmed diagnosis within 2 years according to the International League of Associations for Rheumatology JIA classification criteria (2)
- Followed in one of the pediatric rheumatology clinics participating in the RCT
- Able to access the Internet on a computer
- Willing and able to complete online measures
You may not qualify if:
- Insufficient English reading and speaking skills
- Untreated psychiatric or comorbid disorders or major cognitive impairments leading to inability to understand materials and participate in the SMP group activities.
- Other chronic conditions such as other autoimmune disease, neurologic, orthopedics or other systems disorder (e.g. heart, kidney) that might influence outcome assessments
- Past participation in the last year or participating in another peer-support or self-management program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- The Hospital for Sick Childrencollaborator
- University of Torontocollaborator
- University of Albertacollaborator
- University of Manitobacollaborator
- University of British Columbiacollaborator
Study Sites (1)
Alberta Children's Hospital
Calgary, Alberta, T3B 6A8, Canada
Related Publications (1)
Booth J, Birnie KA, Chomistek K, Santana M, Stinson JN, Adebiyi BO, Brooks J, Guzman J, Hellweg R, Lim LS, Rumsey D, Feldman BM, Tagseth J, Wilson J, Schmeling H. A Virtual Self-Management Intervention for Adolescents With Juvenile Idiopathic Arthritis: Protocol for the VISTA-JIA Randomized Controlled Trial. JMIR Res Protoc. 2025 Jun 27;14:e69539. doi: 10.2196/69539.
PMID: 40577780DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The research team and all participants will be aware which arm they are enrolled in throughout the study.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2023
First Posted
December 28, 2023
Study Start
December 13, 2023
Primary Completion
December 1, 2025
Study Completion
March 1, 2026
Last Updated
December 9, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share